A Glucose Spike Is Not a Diagnosis

Continuous glucose monitors have transformed diabetes care and made glucose dynamics visible in a way that finger-stick measurements never could. That visibility has also created a new wellness market in which people without diabetes are encouraged to optimise every post-meal excursion.

The central message is usually simple: glucose spikes are harmful, flatter curves are healthier, and foods should be judged by the shape they produce on a sensor.

The problem is that normal physiology is dynamic.

After a carbohydrate-containing meal, glucose enters the circulation, pancreatic beta cells secrete insulin, tissues increase glucose uptake and hepatic glucose production is suppressed. Blood glucose then returns toward baseline. A rise after eating is therefore not, by itself, evidence of metabolic dysfunction.

The clinically meaningful question is not whether glucose rose. It is how high it rose, for how long, how quickly it recovered, what the baseline state was, and whether the person has diabetes, prediabetes or normal glucose regulation.

Healthy people have postprandial excursions

CGM studies in healthy adults show clear post-meal glucose variability.

That should not be surprising. The system is designed to respond to nutrient intake.

Studies of people without diabetes have reported ordinary meal-related peaks, substantial between-person variation and occasional values that would look dramatic if removed from context and posted as screenshots.

This does not imply that every excursion is irrelevant. It means that a visible excursion is not itself a diagnosis.

The same numerical peak can have different implications in a person with established diabetes, a person with prediabetes and a metabolically healthy person. Population context matters.

That is one reason the growing use of CGMs in healthy populations needs more interpretive caution than the devices themselves often suggest.

A flatter curve is not automatically a healthier meal

The strongest conceptual error in glucose optimisation is treating one biomarker as the objective function for the entire diet.

A meal containing lentils, vegetables and fruit may produce a higher immediate glucose response than a meal dominated by cheese and processed meat. It does not follow that the second meal is the healthier long-term choice.

Meals differ in fibre, protein, micronutrients, saturated fat, sodium, energy density, food structure, satiety and many other properties. Long-term health cannot be inferred from one acute curve.

This is a classic single-metric optimisation problem.

Once a variable becomes visible, people start treating it as if it were the outcome that matters most. The graph acquires moral meaning.

The same mistake appears with body weight, CRP, cortisol and heart rate. A useful measurement becomes less useful when it is mistaken for the whole system.

CGMs in people without diabetes remain an emerging use case

For diabetes, the clinical value of CGM is established in many treatment contexts.

For healthy people, the evidence is much less mature.

A 2026 systematic review and meta-analysis of CGM use in non-diabetic populations included 23 studies and more than 1,000 participants. The authors found some behavioural and glucose-related effects overall, but no consistent benefit in healthy normoglycaemic participants and no significant reduction in BMI. People with prediabetes appeared more likely to benefit.

That is an important distinction.

A device can produce interesting data without having demonstrated that routine use improves long-term outcomes in everyone.

This is particularly relevant when wellness platforms transform raw glucose measurements into proprietary scores. The score may be algorithmically precise while the clinical meaning of small differences remains uncertain.

Measurement precision is not interpretive certainty

CGMs estimate glucose in interstitial fluid rather than measuring blood glucose directly.

The two track closely, but not perfectly. There is physiological lag, sensor error and normal biological variability. Compression artefacts and day-to-day differences can also affect readings.

For diabetes management, these limitations are known and accounted for in clinical use.

For healthy users comparing two meals that differ by a few milligrams per decilitre, the uncertainty matters much more.

A seven-point difference between meals on different days may reflect a real physiological difference, sensor noise, sleep, recent exercise, the previous meal, meal timing or several factors together.

The existence of a graph does not remove measurement error.

Glucose and insulin are not interchangeable villains

Another common narrative says that if glucose spikes are bad, insulin spikes must also be bad.

But insulin is part of the mechanism that restores glucose toward baseline.

Controlled feeding studies demonstrate why the simplistic model breaks down. Adding protein to carbohydrate can increase insulin secretion while reducing the postprandial glucose response. Whey protein is particularly insulinogenic.

So a meal can produce a “better” glucose curve and a larger insulin response.

If both variables are treated as independent toxins, the framework contradicts itself.

The more coherent interpretation is that an acute insulin response is part of normal nutrient handling. Chronic hyperinsulinaemia in insulin-resistant states is a different physiological question from appropriate post-meal insulin secretion.

The carbohydrate-insulin model is more nuanced than social media presents it

The strongest popular version of the carbohydrate-insulin model suggests that carbohydrate causes insulin spikes, insulin drives nutrients into adipose tissue, and therefore insulin is the main cause of fat gain.

That model contains real physiology but does not adequately explain common obesity on its own.

Controlled feeding studies and critical reviews have not consistently supported the strongest predictions of the model. Energy intake, appetite, food quality, protein, fibre, sleep, physical activity and environmental factors all contribute to weight regulation.

Insulin is important. It is not a loophole in energy balance.

The more useful question is how different dietary patterns affect appetite, adherence, energy intake and metabolic health over time, not whether insulin rose after lunch.

Vinegar and meal order show why surrogate outcomes matter

Some popular “glucose hacks” genuinely affect postprandial glucose.

Meta-analyses have found that vinegar consumed with meals can modestly reduce post-meal glucose and insulin responses. Randomized meal-order studies have shown that eating vegetables and protein before carbohydrate can lower early glucose excursions compared with eating carbohydrate first.

Those findings are real.

The overreach occurs when an acute biomarker effect is presented as proof of a long-term health benefit for everyone.

Lowering the area under a two-hour glucose curve is not the same thing as demonstrating fewer cardiovascular events, less diabetes or lower mortality.

The intervention may eventually prove useful. The surrogate endpoint cannot substitute for the clinical endpoint without evidence connecting them.

This is one of the most common mistakes in health communication: the measurable intermediate outcome becomes the outcome that matters.

Fruit exposes the weakness of glucose-only thinking

Whole fruit is an especially useful counterexample.

Fruit contains carbohydrate and can raise glucose. If the only objective is to minimise the visible peak, avoiding fruit may look rational.

But dietary recommendations are based on broader health outcomes.

Whole fruit contains fibre, water, micronutrients and bioactive compounds. Prospective evidence generally associates higher whole-fruit intake with lower risk of type 2 diabetes and cardiovascular disease.

There is no contradiction between those findings and a visible glucose response.

The contradiction appears only if one assumes that a flatter glucose curve is the definition of a healthier food.

Food matrix, dose and long-term dietary pattern matter.

Glycaemic variability is not one spike

The phrase glucose spike is not a standardised clinical variable.

Glycaemic variability can be described using standard deviation, coefficient of variation, mean amplitude of glycaemic excursions, time above range and other metrics. Two people can have the same maximum glucose value and completely different overall variability.

A single peak also says nothing about duration or recovery.

This matters because screenshots favour maxima. Clinical interpretation generally requires the full time series.

The visual salience of the highest point is not the same thing as physiological importance.

The deeper mistake is treating health as flatness

Glucose-spike culture is part of a broader wellness tendency to treat stability as synonymous with health.

Flat glucose.

Low cortisol.

No inflammatory response.

No insulin peaks.

But healthy biological systems respond to perturbations.

A meal changes glucose and insulin. Exercise changes heart rate and inflammatory signalling. Waking changes cortisol. The relevant property is often the ability to respond appropriately and recover.

For glucose, this means that regulated recovery is generally more informative than the mere existence of a post-meal rise.

Pathology can involve excessive magnitude, prolonged exposure, impaired recovery or inappropriate response. The existence of the response is not itself the disease.

When glucose data deserve attention

None of this is an argument for ignoring glucose abnormalities.

Repeated unusual values, symptoms, pregnancy, medication, known risk factors, prediabetes or diabetes can justify formal assessment. Clinical diagnosis relies on validated measures such as fasting plasma glucose, HbA1c and oral glucose-tolerance testing in the appropriate context.

CGM can add valuable information, especially in established diabetes.

The mistake is not using glucose data. It is treating consumer optimisation of every excursion as if it had the same evidential foundation as diabetes management.

Those are different use cases with different evidence.

What the evidence supports

Post-meal glucose rises are normal. Greater or prolonged hyperglycaemia can be clinically important. CGMs are highly useful for many people with diabetes and may provide behavioural or metabolic value in selected non-diabetic populations, particularly people with prediabetes.

Meal order, physical activity and vinegar can alter acute glucose responses. Protein can reduce glucose while increasing insulin. Whole fruit can raise glucose and still belong to a dietary pattern associated with better long-term outcomes.

The defensible conclusion is therefore not that glucose spikes never matter.

It is that a glucose trace is one measurement inside a larger metabolic system, not a diagnosis and not a complete ranking of food quality.

Once that distinction is preserved, the data become more useful and less theatrical.

---

References

1. Hanefeld M, et al. Continuous Glucose Profiles in Healthy People With Fixed Meal Times and Under Everyday Life Conditions. 2022. https://pubmed.ncbi.nlm.nih.gov/35876145/

2. Freckmann G, et al. Continuous glucose profiles in healthy subjects under everyday life conditions and after different meals. 2007. https://pubmed.ncbi.nlm.nih.gov/19885137/

3. Liao X, Li Y, Tang S, et al. Continuous glucose monitoring in non-diabetic populations: a systematic review of observational and interventional studies with meta-analysis. European Journal of Medical Research. 2026;31:397. https://doi.org/10.1186/s40001-026-03920-0

4. Spartano NL, et al. Expert Clinical Interpretation of Continuous Glucose Monitor Reports From Individuals Without Diabetes. 2026. https://pubmed.ncbi.nlm.nih.gov/39936548/

5. Jensen MT, et al. Glycemic variability assessed using continuous glucose monitoring in individuals without diabetes and associations with cardiometabolic risk markers: A systematic review and meta-analysis. 2024. https://pubmed.ncbi.nlm.nih.gov/38401227/

6. Wolever TMS, et al. The Effect of Adding Protein to a Carbohydrate Meal on Postprandial Glucose and Insulin Responses: A Systematic Review and Meta-Analysis. 2024. https://pubmed.ncbi.nlm.nih.gov/39019167/

7. Hall KD. A review of the carbohydrate-insulin model of obesity. European Journal of Clinical Nutrition. 2017. https://pubmed.ncbi.nlm.nih.gov/28074888/

8. Shishehbor F, Mansoori A, Shirani F. Vinegar consumption can attenuate postprandial glucose and insulin responses: a systematic review and meta-analysis of clinical trials. Diabetes Research and Clinical Practice. 2017;127:1–9. https://pubmed.ncbi.nlm.nih.gov/28292654/

9. Alalwan TA, et al. Postprandial Glucose and Insulin Response to Meal Sequence Among Healthy Adults: A Randomized Controlled Crossover Trial. 2024. https://pubmed.ncbi.nlm.nih.gov/39559800/

10. American Diabetes Association. Diabetes Technology: Standards of Care in Diabetes—2026. Diabetes Care. 2026. https://diabetesjournals.org/care/article/49/Supplement_1/S150/163922/7-Diabetes-Technology-Standards-of-Care-in

---

This article discusses population-level evidence and interpretation of glucose measurements. It is not intended to diagnose diabetes or other metabolic conditions.